Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram for Depression after TBI
NCT01368432Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Apr 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Escitalopram oxalate oral solution in major depressive disorder (MDD), sponsored by Johns Hopkins University. Started Apr 2010; status: completed.
02
Drugs
Escitalopram oxalate oral solution
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01368432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01368432.